Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated ...

The president reportedly lost 20 lbs. between his first and second term in office, according to his physical exam summaries ...

We're in the height of the weight-loss revolution and now a new oral form has just been launched in the U.S. Dr. Jandial ...

Early signs show popular weight loss drugs may curb more than just food cravings. GLP-1’s like Ozempic, Mounjaro may also ...

In a phase IIIb trial of adults with active psoriatic arthritis (PsA) and obesity or overweight, adding the GLP-1 drug ...

Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic ...

And in a phase III trial win, Foresee Pharmaceuticals said its long-acting gonadotropin-releasing hormone agonist leuprolide ...

TUESDAY, Jan. 6, 2026 (HealthDay News) — A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo ...

Starting today, the Wegovy pill is available at more than 70,000 pharmacies, including CVS and Costco; telehealth providers ...

Millions of Americans are using GLP-1s. But so far, there has been comparatively less research on what happens when users ...

It’s the latest move in the race by drug companies to corner more of the highly lucrative obesity drug market.

Departed Gilead executive lands at new home © 2026 American City Business Journals. All rights reserved. Use of and/or ...